- Home
- ATNM vs SNT Comparison
ATNM vs SNT Comparison
Compare ATNM & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- SNT
- Stock Information
- Founded
- ATNM 2000
- SNT 1965
- Country
- ATNM United States
- SNT Canada
- Employees
- ATNM N/A
- SNT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- SNT Telecommunications Equipment
- Sector
- ATNM Health Care
- SNT Telecommunications
- Exchange
- ATNM Nasdaq
- SNT Nasdaq
- Market Cap
- ATNM 56.5M
- SNT 64.6M
- IPO Year
- ATNM N/A
- SNT 1993
- Fundamental
- Price
- ATNM $1.22
- SNT $3.45
- Analyst Decision
- ATNM Strong Buy
- SNT
- Analyst Count
- ATNM 5
- SNT 0
- Target Price
- ATNM $10.20
- SNT N/A
- AVG Volume (30 Days)
- ATNM 319.6K
- SNT 73.4K
- Earning Date
- ATNM 11-14-2024
- SNT 11-12-2024
- Dividend Yield
- ATNM N/A
- SNT N/A
- EPS Growth
- ATNM N/A
- SNT N/A
- EPS
- ATNM N/A
- SNT 0.06
- Revenue
- ATNM $81,000.00
- SNT $34,455,000.00
- Revenue This Year
- ATNM $186.10
- SNT N/A
- Revenue Next Year
- ATNM $19,248.94
- SNT N/A
- P/E Ratio
- ATNM N/A
- SNT $54.86
- Revenue Growth
- ATNM N/A
- SNT 2.04
- 52 Week Low
- ATNM $1.16
- SNT $1.08
- 52 Week High
- ATNM $10.24
- SNT $3.35
- Technical
- Relative Strength Index (RSI)
- ATNM 35.90
- SNT 71.93
- Support Level
- ATNM $1.16
- SNT $2.90
- Resistance Level
- ATNM $1.29
- SNT $3.09
- Average True Range (ATR)
- ATNM 0.09
- SNT 0.19
- MACD
- ATNM 0.00
- SNT 0.00
- Stochastic Oscillator
- ATNM 21.54
- SNT 98.16
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.